Edwin Peguero

467 total citations
25 papers, 254 citations indexed

About

Edwin Peguero is a scholar working on Neurology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edwin Peguero has authored 25 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 10 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edwin Peguero's work include Brain Metastases and Treatment (9 papers), Glioma Diagnosis and Treatment (7 papers) and Cancer Treatment and Pharmacology (5 papers). Edwin Peguero is often cited by papers focused on Brain Metastases and Treatment (9 papers), Glioma Diagnosis and Treatment (7 papers) and Cancer Treatment and Pharmacology (5 papers). Edwin Peguero collaborates with scholars based in United States and Puerto Rico. Edwin Peguero's co-authors include Bassel Abou‐Khalil, Toufic Fakhoury, Sepideh Mokhtari, Yolanda Piña, Matthew Chung, Peter Forsyth, Tawee Tanvetyanon, Robert Macaulay, Miguel A. Labrador and Solmaz Sahebjam and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Epilepsia.

In The Last Decade

Edwin Peguero

18 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin Peguero United States 8 122 58 54 50 43 25 254
Erin Murphy United States 7 47 0.4× 69 1.2× 36 0.7× 26 0.5× 15 0.3× 9 222
Daniel Talmasov United States 7 47 0.4× 69 1.2× 50 0.9× 130 2.6× 77 1.8× 13 372
Anne Hayman United States 8 24 0.2× 39 0.7× 68 1.3× 22 0.4× 41 1.0× 18 274
Laura Seynaeve Belgium 10 51 0.4× 63 1.1× 49 0.9× 52 1.0× 25 0.6× 18 314
Merry Chen United States 9 54 0.4× 51 0.9× 79 1.5× 27 0.5× 39 0.9× 16 245
Lawrence A. Zeidman United States 13 31 0.3× 161 2.8× 19 0.4× 8 0.2× 13 0.3× 46 425
Rebecca McClellan United States 12 42 0.3× 29 0.5× 33 0.6× 9 0.2× 14 0.3× 21 485
Alain de Lotbinière United States 8 103 0.8× 70 1.2× 57 1.1× 13 0.3× 37 0.9× 12 317
Eun Kyung Lee South Korea 10 88 0.7× 25 0.4× 16 0.3× 85 1.7× 19 0.4× 28 300
Elena Cesarini Italy 11 157 1.3× 27 0.5× 21 0.4× 59 1.2× 22 0.5× 21 389

Countries citing papers authored by Edwin Peguero

Since Specialization
Citations

This map shows the geographic impact of Edwin Peguero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Peguero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Peguero more than expected).

Fields of papers citing papers by Edwin Peguero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin Peguero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Peguero. The network helps show where Edwin Peguero may publish in the future.

Co-authorship network of co-authors of Edwin Peguero

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin Peguero. A scholar is included among the top collaborators of Edwin Peguero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin Peguero. Edwin Peguero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salazar, Andrea, et al.. (2025). The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis. Cells. 14(10). 739–739. 1 indexed citations
2.
Mokhtari, Sepideh, et al.. (2024). NCMP-28. CASE REPORT: REFRACTORY MYASTHENIA GRAVIS FLARE INDUCED BY IMMUNE CHECK POINT INHIBITOR. Neuro-Oncology. 26(Supplement_8). viii222–viii223.
3.
4.
Shah, Anand, et al.. (2023). Neurological Complications of Immune Checkpoint Inhibitors (P12-13.004). Neurology. 100(17_supplement_2). 1 indexed citations
5.
Liu, James K., Junmin Whiting, Krupal Patel, et al.. (2022). Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology department. Journal of Neuro-Oncology. 160(2). 517–525. 6 indexed citations
6.
Piña, Yolanda, et al.. (2022). NCMP-17. PLASMA EXCHANGE FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ACUTE DEMYELINATING POLYNEUROPATHY REFRACTORY TO IVIG. Neuro-Oncology. 24(Supplement_7). vii194–vii194. 1 indexed citations
7.
Gaballa, Sameh, et al.. (2022). Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib. Journal of Neurological Surgery Reports. 83(1). e19–e22.
8.
Piña, Yolanda, et al.. (2021). Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis. Cureus. 13(7). e16337–e16337. 11 indexed citations
9.
Vogelbaum, Michael A., Arnold B. Etame, Nam Tran, et al.. (2021). A Prospective Validation Study of the First 3D Digital Exoscope for Visualization of 5-ALA–Induced Fluorescence in High-Grade Gliomas. World Neurosurgery. 149. e498–e503. 18 indexed citations
10.
Peguero, Edwin, et al.. (2021). Software-Defined Vector Processing on Manycore Fabrics. 392–406. 1 indexed citations
11.
Piña, Yolanda, Nam Tran, Peter Forsyth, Sepideh Mokhtari, & Edwin Peguero. (2021). P08.01 Immune-Related Acute Motor Axonal Neuropathy: A Small Case Series and Review of the Literature. Neuro-Oncology. 23(Supplement_2). ii26–ii26.
12.
Piña, Yolanda, Brittany Evernden, Nikhil I. Khushalani, et al.. (2021). Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature. SHILAP Revista de lepidopterología. 9. 2050313X211042215–2050313X211042215. 2 indexed citations
13.
Fusco, Michael, Yolanda Piña, Robert Macaulay, et al.. (2021). Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas. Cancer Control. 28. 2895458061–2895458061. 13 indexed citations
14.
Peguero, Edwin, et al.. (2020). Dyskinesia during concomitant usage of phenytoin and capecitabine. Postgraduate Medical Journal. 97(1152). 629–629.
15.
Chung, Matthew, et al.. (2020). Immunotherapy Induced Myasthenic-Like Syndrome in a Metastatic Melanoma Patient With Amyotrophic Lateral Sclerosis. Clinical Medicine Insights Oncology. 14. 2282673768–2282673768. 2 indexed citations
16.
Piña, Yolanda, Michael Fusco, Robert Macaulay, et al.. (2019). Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma. Journal of Neurology. 267(3). 783–790. 7 indexed citations
17.
18.
Kasischke, Karl A., et al.. (2019). Immediate Transfer for Clot Extraction in a Young Woman With Leukemia and Asparaginase-Associated Acute Cerebral Vein Thrombosis. The Neurohospitalist. 10(1). 58–63. 4 indexed citations
19.
Peguero, Edwin, et al.. (1995). Self‐Injury and Incontinence in Psychogenic Seizures. Epilepsia. 36(6). 586–591. 73 indexed citations
20.
Fakhoury, Toufic, Bassel Abou‐Khalil, & Edwin Peguero. (1994). Differentiating Clinical Features of Right and Left Temporal Lobe Seizures. Epilepsia. 35(5). 1038–1044. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erin Murphy Breakdown of academic impact, for papers by Daniel Talmasov Breakdown of academic impact, for papers by Anne Hayman Breakdown of academic impact, for papers by Laura Seynaeve Breakdown of academic impact, for papers by Merry Chen Breakdown of academic impact, for papers by Lawrence A. Zeidman Breakdown of academic impact, for papers by Rebecca McClellan Breakdown of academic impact, for papers by Alain de Lotbinière Breakdown of academic impact, for papers by Eun Kyung Lee Breakdown of academic impact, for papers by Elena Cesarini
Rankless by CCL
2026